Type 1 diabetes and disordered eating — known as T1DE — represents an escalating yet underrecognized health emergency with profound physical and psychological effects. Unlike bulimia nervosa, which media coverage often equates with T1DE, the condition involves diverse disordered eating patterns among individuals with type 1 diabetes mellitus (T1DM), including insulin restriction, extreme dietary behaviors, and excessive exercise. These actions extend beyond weight control, instead reflecting deep psychological struggles tied to diabetes management and body dissatisfaction.
The autoimmune nature of T1DM means the body stops insulin production, requiring lifelong dependence on monitoring and insulin therapy. Approximately 400,000 people in the UK have T1DM, with cases most commonly emerging in childhood. Daily glucose checks, through finger-prick tests or continuous monitors, and precise insulin dosing, often via injections or pumps, become essential. For someone with T1DE, these tools are weaponized against their health. Intentional insulin reduction, whether through deliberate omission or manipulation like heating insulin or injecting into scarred skin, can cause rapid weight loss. However, reintroducing insulin triggers sudden weight gain and fluid retention, perpetuating the cycle of restriction.
People with T1DE face a mortality risk three times higher than those with T1DM alone. Insulin restriction leads to dangerous blood glucose and ketone spikes, raising the threat of diabetic ketoacidosis (DKA), a condition necessitating emergency hospitalization. Research involving 78 patients in a specialized T1DE service demonstrated that integrated care lowered HbA1c levels, reduced DKA admissions, and decreased severe hypoglycemic episodes over a year. Despite these improvements, access to such services varies widely across the UK. Most patients remain split between diabetes and eating disorder clinics, lacking the coordinated supervision required for safe treatment.
Diagnostic challenges and missing guidelines
A 2024 parliamentary investigation highlighted the need for dedicated T1DE funding, standardized diagnostic guidelines, and a national treatment framework. The absence of clear diagnostic criteria, neither the ICD-11 nor DSM-5 recognize T1DE as a distinct disorder, leaves clinicians without structured guidance. While the Royal College of Psychiatrists has proposed diagnostic standards, formal identification still requires evaluation by a psychiatrist or eating disorder specialist. The difficulty lies in distinguishing T1DE from other causes of insulin restriction, such as needle aversion or diabetes burnout. The defining feature is the overwhelming fear of weight gain and body image distress driving these behaviors.
Diagnosis is further complicated by the fact that many with T1DE appear to have a normal weight. BMI cannot exclude the condition, as insulin omission can occur regardless of body size. Some patients alter glucose readings or carbohydrate logs to deceive insulin pumps into delivering smaller doses. Others binge on sugar or overexercise to raise blood sugar levels. The consequences range from accelerated diabetes complications, including nephropathy, retinopathy, and foot damage, to severe malnutrition, cognitive decline, and mental health deterioration.
Pharmacists, who frequently interact with T1DM patients during prescription renewals, are critical in early detection. Warning signs include erratic glucose levels, repeated DKA hospitalizations, and unexplained weight changes, even when the individual falls within a healthy BMI range. Screening instruments like the Diabetes Eating Problem Survey-Revised (DEPS-R) or the mSCOFF questionnaire can assist, but clinical judgment must accompany their use. A patient who suddenly stops requesting insulin prescriptions, skips appointments, or exhibits signs of diabetes-related distress may be concealing disordered eating patterns.
Building trust to uncover hidden struggles
Effective communication is essential. Healthcare providers must avoid judgmental remarks about weight or glucose management and instead adopt a cooperative approach. Trust develops through consistency, reliability, and a willingness to listen without immediate solutions. For those with T1DE, the fear of judgment often surpasses the desire for help, making early intervention contingent on establishing a secure environment for disclosure.
When T1DE is suspected, referral to a specialist team is necessary. Traditional eating disorder services frequently exclude patients with normal BMI, leaving those with T1DE without treatment options. NHS England pilot initiatives showed that a combined diabetes and eating disorder approach enhances outcomes, but funding limitations persist. Without standardized pathways, patients endure fragmented care, with diabetes specialists unaware of mental health concerns and eating disorder experts missing the physical dangers of insulin restriction.
The psychological treatments used in T1DE care, such as enhanced cognitive behavioral therapy (CBT-E) and family-based interventions, must adapt to address diabetes-specific obstacles. For children, parental education programs have shown potential in preventing early disordered eating. Meanwhile, insulin management during recovery requires a harm-reduction strategy, gradually restoring safe levels instead of abrupt normalization, which can provoke rebound hypoglycemia or worsen long-term complications.
Technology’s dual role in treatment and risk
Technology like continuous glucose monitors (CGMs) and insulin pumps can both aid and complicate recovery. CGM data may uncover insulin restriction patterns, but patient consent is required for data sharing. Hybrid closed-loop systems could provide stability during recovery, though their use demands careful oversight to prevent reinforcing disordered behaviors. Nutritional counseling must shift beyond strict carbohydrate counting to encourage balanced eating, with gradual, sustainable adjustments rather than abrupt changes.
The most successful care models merge diabetes and mental health expertise, with regular communication between specialists. Pharmacists can contribute by identifying concerns for diabetes teams and advocating for shared care plans. Without national funding and standardized training, however, the system remains disjointed. The planned 2026 launch of a CPD-accredited online training program for healthcare professionals aims to address some gaps, but the core issue, fair access to specialist services, stays unresolved.